Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 1294 entries
View as:

Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT03574597 Org: User:
Start: 10/24/18 End: 06/29/23 Due: 06/29/24

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

Phase: N/A Priority: Normal
NCT ID: NCT04777396 Org: User:
Start: 05/18/21 End: 10/23/26 Due: 10/23/27

To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan

Phase: N/A Priority: Normal
NCT ID: NCT02207218 Org: User:
Start: 08/04/14 End: 11/10/20 Due: 11/10/21

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT00887874 Org: User:
Start: 05/31/09 End: 09/30/09 Due: 09/30/10

Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01847989 Org: User:
Start: 01/31/03 End: 05/31/03 Due: 05/31/04

A Study to Compare the Uptake Into the Blood of Two Strengths of Somapacitan After Injection Under the Skin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03905850 Org: User:
Start: 03/29/19 End: 07/15/19 Due: 07/15/20

A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Pens

Phase: N/A Priority: Normal
NCT ID: NCT04152915 Org: User:
Start: 11/25/19 End: 05/25/20 Due: 05/25/21

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01597713 Org: User:
Start: 05/31/12 End: 10/31/12 Due: 10/31/13

A Study to Evaluate Safety and Effectiveness in Patients of All Age Groups Excluding Less Than 12 Months Old Infants With Diabetes Mellitus in Routine Clinical Practice in Korea

Phase: N/A Priority: Normal
NCT ID: NCT02779413 Org: User:
Start: 06/02/16 End: 06/24/19 Due: 06/24/20

A Two Part Trial Investigating the Safety of NN9925 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01087645 Org: User:
Start: 03/12/10 End: 09/16/10 Due: 09/16/11

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in India

Phase: N/A Priority: Normal
NCT ID: NCT01351922 Org: User:
Start: 04/30/11 End: 09/30/11 Due: 09/30/12

Safety of Insulin Detemir in Children With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00605137 Org: User:
Start: 05/21/04 End: 04/23/05 Due: 04/23/06

Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01579955 Org: User:
Start: 03/10/99 End: 03/09/10 Due: 03/09/11

Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03015220 Org: User:
Start: 01/10/17 End: 07/12/18 Due: 07/12/19

A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01174303 Org: User:
Start: 08/31/10 End: 11/30/10 Due: 11/30/11

A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)

Phase: N/A Priority: Normal
NCT ID: NCT03611322 Org: User:
Start: 08/08/18 End: 01/07/19 Due: 01/07/20

A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin

Phase: N/A Priority: Normal
NCT ID: NCT00931476 Org: User:
Start: 04/06/00 End: 06/08/00 Due: 06/08/01

A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Thailand

Phase: N/A Priority: Normal
NCT ID: NCT00805922 Org: User:
Start: 12/31/08 End: 09/30/09 Due: 09/30/10

A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)

Phase: N/A Priority: Normal
NCT ID: NCT04880850 Org: User:
Start: 05/14/21 End: 06/16/22 Due: 06/16/23

Within-subject Variability of Insulin Detemir in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01497535 Org: User:
Start: 05/27/04 End: 10/31/04 Due: 10/31/05

Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial

Phase: N/A Priority: Normal
NCT ID: NCT02541942 Org: User:
Start: 04/03/15 End: 04/15/16 Due: 04/15/17

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin

Phase: N/A Priority: Normal
NCT ID: NCT06323161 Org: User:
Start: 03/26/24 End: 10/24/25 Due: 10/24/26

Effect of NN5401 in Japanese Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01051102 Org: User:
Start: 01/31/10 End: 04/30/10 Due: 04/30/11

General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT06807190 Org: User:
Start: 04/15/25 End: 01/31/28 Due: 01/31/29

A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide

Phase: N/A Priority: Normal
NCT ID: NCT04228354 Org: User:
Start: 01/29/20 End: 06/01/20 Due: 06/01/21